AMPE Ampio Pharmaceuticals Inc

Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.

$0.97  -0.10 (-9.35%)
As of 12/03/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/18/2011
Outstanding shares:  202,129,686
Average volume:  1,066,729
Market cap:   $216,278,764
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03209T109
ISIN:        US03209T1097
Sedol:      B5BNLD2
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   11.28
PS ratio:   0.00
Return on equity:   -89.54%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy